7 research outputs found

    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (<i>Trichosurus vulpecula</i>)

    No full text
    <div><p>Oral-delivery <i>Mycobacterium bovis</i> bacillus Calmette-Guérin (BCG) vaccine in a lipid matrix has been shown to confer protection against <i>M</i>. <i>bovis</i> infection and reduce the severity of tuberculosis (TB) when fed to brushtail possums (<i>Trichosurus vulpecula</i>), the major wildlife vector of bovine TB in New Zealand. Here we demonstrate the feasibility of aerial delivery of this live vaccine in bait form to an <i>M</i>. <i>bovis</i>-infected wild possum population, and subsequently assess vaccine uptake and field efficacy. Pre-trial studies indicated a resident possum population at very low density (<0.6 possums/ha) at the field site, with a 5.1% prevalence of macroscopic TB lesions. Pilot studies indicated that flavoured lipid matrix baits in weather-proof sachets could be successfully sown aerially via helicopter and were palatable to, and likely to be consumed by, a majority of wild possums under free-choice conditions. Subsequently, sachet-held lipid baits containing live BCG vaccine were sown at 3 baits/ha over a 1360 ha area, equating to >5 baits available per possum. Blood sampling conducted two months later provided some evidence of vaccine uptake. A necropsy survey conducted one year later identified a lower prevalence of culture-confirmed <i>M</i>. <i>bovis</i> infection and/or gross TB lesions among adult possums in vaccinated areas (1.1% prevalence; 95% CI, 0–3.3%, n = 92) than in unvaccinated areas (5.6%; 0.7–10.5%, n = 89); P = 0.098. Although not statistically different, the 81% efficacy in protecting possums against natural infection calculated from these data is within the range of previous estimates of vaccine efficacy in trials where BCG vaccine was delivered manually. We conclude that, with further straightforward refinement to improve free-choice uptake, aerial delivery of oral BCG vaccine is likely to be effective in controlling TB in wild possums. We briefly discuss contexts in which this could potentially become an important complementary tool in achieving national eradication of TB from New Zealand wildlife.</p></div

    Location of the Muzzle Station/Clarence Reserve study sites within the northern South Island high country region of New Zealand.

    No full text
    <p>Four main study blocks are depicted in the regional-scale map (left) with vaccine blocks outlined in blue and non-treatment blocks in red. The yellow lines depict the inner 700 ha areas of the two vaccine blocks over which vaccine was deployed in September 2011. The green rectangle depicts the 50 ha block on which the pilot aerial baiting and bait contact studies were conducted.</p

    Summary of results from fate-of-bait pilot trials, to determine the contact and removal rates of flavoured lipid baits from habitat on Muzzle Station/Clarence Reserve over 3–7 day periods and to identify the likely wildlife species involved.

    No full text
    <p>Summary of results from fate-of-bait pilot trials, to determine the contact and removal rates of flavoured lipid baits from habitat on Muzzle Station/Clarence Reserve over 3–7 day periods and to identify the likely wildlife species involved.</p

    Details of possums and pigs necropsied from wildlife TB surveys conducted on Muzzle Station/Clarence Reserve between spring 2009 to autumn 2011 (final surveillance was 6 months prior to vaccine deployment).

    No full text
    <p>Details of possums and pigs necropsied from wildlife TB surveys conducted on Muzzle Station/Clarence Reserve between spring 2009 to autumn 2011 (final surveillance was 6 months prior to vaccine deployment).</p

    Summary of LPA responses to PPD-B—stimulation among possums captured from a non-vaccinated block and two vaccine blocks, two months following aerial vaccine deployment.

    No full text
    <p>Diamond symbols indicate LPA responses to PPD-B in terms of a stimulation index. Left-fig, data from 61 possums, highlighting 2 animals that were excluded from subsequent analyses on the basis of likely pre-existing <i>M</i>. <i>bovis</i> infection (red symbols). Right-fig, data from 59 possums (excluding the 2 likely infected cases) re-plotted on a reduced scale graph. Yellow symbols represent responses of individual animals that were greater than the 99 percentile distribution of the control values (i.e. > control mean + 3 standard deviations, indicated by the red dashed line).</p

    Overview of the flight characteristics during aerial sowing of flavoured lipid baits in sachets during the pilot trial and during the main vaccine trial (the latter containing live <i>M</i>. <i>bovis</i> BCG).

    No full text
    <p>Overview of the flight characteristics during aerial sowing of flavoured lipid baits in sachets during the pilot trial and during the main vaccine trial (the latter containing live <i>M</i>. <i>bovis</i> BCG).</p
    corecore